{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:40:16Z","timestamp":1791387616073,"version":"4.3.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Gastroenterol","Clinical and Translational Gastroenterology"],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Acute liver failure (ALF) and acute-on-chronic liver failure (AOCLF) are critical medical conditions with urgent therapy requirements. When ALF or AOCLF are due to alcohol intoxication or based on chronic alcohol abuse, virtually, no therapeutic options are available as liver transplantation is prohibited. In this case series, treatment of alcohol-induced ALF\/AOCLF with adipose--derived stem cells (ASC) was tested under compassionate use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>ASC from 2 donors were isolated, cultured, and expanded by established protocols. ASC were administered to 3 individuals with either ALF or AOCLF due to alcohol abuse under compassionate use. Clinical presentation, serum measurements, and other diagnostic methods were compiled before ASC treatment and during the disease course after ASC administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Three patients were admitted to the Department of Gastroenterology, Hepatology, and Infectious Diseases (University Hospital Magdeburg) with acute or AOCLF due to alcohol abuse. All 3 patients presented in impaired general condition and with elevated, in 1 case drastically elevated, serum liver enzyme concentrations. Treatment with ASC led to improvements in general condition and reduction of serum transaminases. In 2 cases, reduction of liver stiffness and increase of liver function by the C\n                      <jats:sup>13<\/jats:sup>\n                      methacetin breath test were observed after ASC treatment. Recovery to a normal condition was achieved between 1 and 2 months after ASC treatment. No adverse effects associated to ASC treatment were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>ASC treatment may be a feasible option to enhance recovery from alcohol-induced ALF or AOCLF. ASC treatment seems safe in the presented cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.14309\/ctg.0000000000000095","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T19:24:33Z","timestamp":1574882673000},"page":"e00095","source":"Crossref","is-referenced-by-count":9,"title":["Three Cases of Alcohol-Induced Acute-On-Chronic Liver Failure With Successful Support by Adipose-Derived Stem Cells"],"prefix":"10.14309","volume":"10","author":[{"given":"Tobias","family":"G\u00f6tze","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krueger","sequence":"additional","affiliation":[{"name":"Oxacells AG, Potsdam, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Meutsch","sequence":"additional","affiliation":[{"name":"Oxacells AG, Potsdam, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"D\u00f6rfel","sequence":"additional","affiliation":[{"name":"Oxacells AG, Potsdam, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Born","sequence":"additional","affiliation":[{"name":"Oxacells AG, Potsdam, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Peter","family":"Sowa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12]]},"reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cgh.2012.02.016","article-title":"Etiologies and outcomes of acute liver failure in Germany","volume":"10","author":"Hadem","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: An update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J Hepatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13287-018-0972-4","article-title":"Progress in mesenchymal stem cell-based therapy for acute liver failure","volume":"9","author":"Wang","year":"2018","journal-title":"Stem Cel Res Ther"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: Implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.21704","article-title":"Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes","volume":"46","author":"Banas","year":"2007","journal-title":"Hepatology"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1634\/stemcells.2008-0034","article-title":"IFATS collection: In vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury","volume":"26","author":"Banas","year":"2008","journal-title":"Stem Cells"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/hep.22236","article-title":"Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo","volume":"47","author":"van Poll","year":"2008","journal-title":"Hepatol (Baltimore, MD)"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1089\/scd.2012.0176","article-title":"Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants","volume":"21","author":"Lin","year":"2012","journal-title":"Stem Cell Dev"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fimmu.2018.01642","article-title":"Characteristics and immunomodulating functions of adipose-derived and bone marrow-derived mesenchymal stem cells across defined human leukocyte antigen barriers","volume":"9","author":"Waldner","year":"2018","journal-title":"Front Immunol"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"4197857","DOI":"10.1155\/2018\/4197857","article-title":"Current perspectives regarding stem cell-based therapy for liver cirrhosis","volume":"2018","author":"Kwak","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R12-20230814","first-page":"e50585","article-title":"Manual isolation of adipose-derived stem cells from human lipoaspirates","author":"Zhu","year":"2013","journal-title":"J Vis Exp"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15171\/bi.2019.20","article-title":"A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product","volume":"9","author":"Born","year":"2019","journal-title":"BioImpacts"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","article-title":"Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: A joint statement of the International federation for adipose therapeutics and science (IFATS) and the International society for cellular therapy (ISCT)","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"Arena","year":"2008","journal-title":"Hepatology"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12072-010-9189-z","article-title":"Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B","volume":"4","author":"Fung","year":"2010","journal-title":"Hepatol Int"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","article-title":"Non-invasive diagnosis and biomarkers in alcohol-related liver disease","volume":"70","author":"Moreno","year":"2019","journal-title":"J Hepatol"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/gut.2010.228478","article-title":"Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis","volume":"60","author":"Di Marco","year":"2011","journal-title":"Gut"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.gtc.2018.01.005","article-title":"Modern management of acute liver failure","volume":"47","author":"Khan","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"R22-20230814","first-page":"714","article-title":"Acute liver failure: A life-threatening disease","volume":"108","author":"Canbay","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3727\/215517916X693159","article-title":"Immunomodulatory effects of adipose tissue-derived stem cells on concanavalin A-induced acute liver injury in mice","volume":"9","author":"Yoshizumi","year":"2017","journal-title":"Cell Med"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13287-015-0040-2","article-title":"Adipose-derived stem cell-based treatment for acute liver failure","volume":"6","author":"Chen","year":"2015","journal-title":"Stem Cel Res Ther"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.surg.2014.12.016","article-title":"Secretome from human adipose-derived stem cells protects mouse liver from hepatic ischemia-reperfusion injury","volume":"157","author":"Lee","year":"2015","journal-title":"Surgery"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","article-title":"Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively","volume":"14","author":"Huang","year":"2016","journal-title":"J Transl Med"},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4103\/0366-6999.179794","article-title":"Interleukin-10 contributes to therapeutic effect of mesenchymal stem cells for acute liver failure via signal transducer and activator of transcription 3 signaling pathway","volume":"129","author":"Ma","year":"2016","journal-title":"Chin Med J"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"E1099","DOI":"10.3390\/ijms17071099","article-title":"Identification of pathways in liver repair potentially targeted by secretory proteins from human mesenchymal stem cells","volume":"17","author":"Winkler","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13287-017-0590-6","article-title":"Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease","volume":"8","author":"de Witte","year":"2017","journal-title":"Stem Cel Res Ther"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.14309\/ctg.0000000000000095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:20:29Z","timestamp":1786544429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.14309\/ctg.0000000000000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/ctg.0000000000000095","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,26]]}}}